Applied Clinical Trials-09-01-2022

Considering caregiver-supported trials to improve patient retention and outcomes.

COVID spotlights the troubling disparity in clinical research representation. How can we remove these barriers?

How optimizing RBQM risk detection reduces the efforts caused by false signals.

Experts discuss solving the EHR-compatibility puzzle in point-of-care trials.

The struggle to translate promising movements in R&D.

Greater flexibility in eCOA solution could reduce need for backups.

Kevin Aniskovich, president and CEO of Jumo Health, discusses its foray into the clinical trials arena, which includes delivering multimedia educational resources to more than 200 trials spanning 90-plus languages in more than 75 countries.

Industry making moves towards better utilizing clinical research as a care option.

Click the title above for a link to open the Applied Clinical Trials September 2022 issue in an interactive PDF format.

Orientation pursuits hit high gear as formal rule compliance inches closer.

Better clinical data needed, as well as strategies for tackling opioid abuse, tobacco use, and food safety.

Series Part 3—Methods for early detection of risk and summary.